Get the Stockscreener App
116.23
1.01%
1.16
After Hours:
116.63
0.40
+0.34%
Overview
News
Price History
Option Chain
Financials
Why RVTY Down?
Discussions
Forecast
Stock Split
Dividend History
Revvity Inc stock is traded at $116.23, with a volume of 603.32K.
It is up +1.01% in the last 24 hours and down -0.09% over the past month.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
See More
Previous Close:
$115.07
Open:
$115.98
24h Volume:
603.32K
Relative Volume:
0.77
Market Cap:
$14.10B
Revenue:
$2.72B
Net Income/Loss:
$254.30M
P/E Ratio:
19.55
EPS:
5.9463
Net Cash Flow:
$564.37M
1W Performance:
+4.39%
1M Performance:
-0.09%
6M Performance:
+2.61%
1Y Performance:
+31.71%
1-Day Range:
$114.71
$117.01
1-Week Range:
$109.17
$117.01
52-Week Range:
$86.30
$129.50
Revvity Inc Stock (RVTY) Company Profile
Name
Revvity Inc
Sector
Industry
Phone
781-663-6900
Address
77 4TH AVENUE, WALTHAM
Compare RVTY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
116.23 | 14.10B | 2.72B | 254.30M | 564.37M | 5.9463 |
|
TMO
Thermo Fisher Scientific Inc
|
521.66 | 199.82B | 42.37B | 6.14B | 7.78B | 15.26 |
|
DHR
Danaher Corp
|
238.83 | 173.66B | 23.74B | 3.89B | 4.98B | 7.93 |
|
A
Agilent Technologies Inc
|
138.14 | 38.64B | 6.51B | 1.29B | 1.37B | 3.82 |
|
IQV
Iqvia Holdings Inc
|
201.43 | 36.52B | 15.32B | 1.41B | 1.96B | 5.95 |
|
IDXX
Idexx Laboratories Inc
|
421.76 | 34.55B | 3.84B | 866.24M | 792.60M | 9.80 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-08-24 | Initiated | Leerink Partners | Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | UBS | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-23-23 | Resumed | Goldman | Buy |
View All
Revvity Inc Stock (RVTY) Latest News
Zacks Research Brokers Raise Earnings Estimates for Revvity - MarketBeat
Revvity Inc. stock rises Tuesday, still underperforms market - MarketWatch
What Are Wall Street Analysts' Target Price for Revvity Stock? - Nasdaq
What Are Wall Street Analysts' Target Price For Revvity Stock? - Barchart
Revvity Broadens Relationship With Genomics England To Advance Genomics in the UK - Technology Networks
Revvity price target lowered to $135 from $140 at Barclays - Yahoo Finance
Charles Schwab Investment Management Inc. Acquires 24,726 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Pathstone Holdings LLC Grows Position in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Brokerages Set Revvity, Inc. (NYSE:RVTY) Price Target at $131.73 - MarketBeat
RVTY (Revvity) Shares Outstanding (EOP) : 122 Mil (As of Sep. 2024) - GuruFocus.com
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Q1 Earnings Forecast for Revvity Issued By Leerink Partnrs - MarketBeat
Wells Fargo Initiates Coverage of Revvity (RVTY) with Equal-Weight Recommendation - MSN
Primecap Management Co. CA Lowers Holdings in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Revvity Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Revvity Partners with Genomics England to Screen 100,000 Newborns for Rare Conditions | RVTY Stock News - StockTitan
Revvity CEO to Present Strategic Update at Evercore ISI HealthCONx Conference | PKI Stock News - StockTitan
Scale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells - BioSpace
Revvity CEO to Present Strategic Update at Evercore ISI HealthCONx Conference | RVTY Stock News - StockTitan
Scale Bio & Revvity Launch Breakthrough Single-Cell Protein Profiling Technology | PKI Stock News - StockTitan
Revvity updates organizational structure - Nasdaq
Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent Transformation - Business Wire
Developing image-based T-cell assays for monitoring apoptosis and CAR expression - News-Medical.Net
Sumitomo Mitsui Trust Group Inc. Purchases 9,473 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Impax Asset Management Group plc Sells 10,233 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Revvity Inc. stock underperforms Friday when compared to competitors - MarketWatch
Select Equity Group, L.P. Reduces Stake in Revvity Inc - GuruFocus.com
RSI Alert: Revvity (RVTY) Now Oversold - Nasdaq
T. Rowe Price Investment Management, Inc. Reduces Stake in Revvi - GuruFocus.com
Janus Henderson Group PLC's Strategic Acquisition of Shares in R - GuruFocus.com
Sivik Global Healthcare LLC Purchases New Position in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Bretton Capital Management LLC Invests $1.41 Million in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Revvity Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
We Think Revvity's (NYSE:RVTY) Healthy Earnings Might Be Conservative - Simply Wall St
Capital Research Global Investors Bolsters Position in Revvity I - GuruFocus.com
Revvity Inc. stock outperforms competitors despite losses on the day - MarketWatch
These Analysts Revise Their Forecasts On Revvity Following Q3 Results - MSN
FY2024 EPS Estimates for Revvity Boosted by Leerink Partnrs - MarketBeat
Revvity stock price target lifted, outperform rating on strong results By Investing.com - Investing.com Canada
TD Cowen Issues Positive Forecast for Revvity (NYSE:RVTY) Stock Price - MarketBeat
Raymond James Issues Positive Forecast for Revvity (NYSE:RVTY) Stock Price - MarketBeat
TD Cowen increases Revvity stock price target, keeps buy on stable signs - Investing.com Canada
Revvity Announces Financial Results for the Third Quarter of 2024 - BioSpace
Revvity, Inc. (NYSE:RVTY) Q3 2024 Earnings Call Transcript - Insider Monkey
Revvity stock price target lifted, outperform rating on strong results - Investing.com India
Revvity beats Q3 expectations, raises full-year EPS outlook - Investing.com India
Revvity Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Revvity Adjusts Revenue Forecast But Lifts Profit Expectations - Finimize
Revvity (NYSE:RVTY) Given New $145.00 Price Target at Sanford C. Bernstein - MarketBeat
Revvity Inc (RVTY) Q3 2024 Earnings Call Highlights: Strong EPS and Cash Flow Amid Market Challenges - GuruFocus.com
KeyBanc maintains $132 target on Revvity amid EPS guidance raise By Investing.com - Investing.com Canada
Revvity Inc Stock (RVTY) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):